Inflammation and hypertension: new understandings and potential therapeutic targets
- PMID: 25432899
- PMCID: PMC4418473
- DOI: 10.1007/s11906-014-0507-z
Inflammation and hypertension: new understandings and potential therapeutic targets
Abstract
Research studying the role of inflammation in hypertension and cardiovascular disease has flourished in recent years; however, the exact mechanisms by which the activated immune cells lead to the development and maintenance of hypertension remain to be elucidated. The objectives of this brief review are to summarize and discuss the most recent findings in the field, with special emphasis on potential therapeutics to treat or prevent hypertension. This review will cover novel immune cell subtypes recently associated to the disease including the novel role of cytokines, toll-like receptors, and inflammasomes in hypertension.
References
-
- Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clinical Science. 2014;126:267–274. - PubMed
-
- Bernardo Rodriguez-Iturbe B. Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension. Clin Exp Nephrol. 2010;14:105–111. - PubMed
-
- Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology. 2003;4:330–336. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
